Hudson Bay Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-772,992
Closed -$30.4M 1064
2023
Q2
$30.4M Buy
772,992
+516,866
+202% +$18.2M 0.22% 92
2023
Q1
$6.23M Buy
+256,126
New +$5.61M 0.05% 257
2018
Q4
Sell
-125,000
Closed -$295K 955
2018
Q3
$295K Hold
125,000
﹤0.01% 650
2018
Q2
$341K Buy
+125,000
New +$345K ﹤0.01% 719

Hudson Bay Capital Management's ISEE Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 772,992 shares — an estimated $30.4M sold.

Hudson Bay Capital Management first reported a position in ISEE in Q2 2018 and held it in 4 quarters. The position peaked at $30.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Hudson Bay Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 772,992 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $30.4M.
  • Hudson Bay Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • Hudson Bay Capital Management's IVERIC bio, Inc. Common Stock position peaked at $30.4M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.